Basics Ventyx Biosciences, Inc. IPO Date: October 21, 2021 Sector: Healthcare Industry: Biotech Market Cap: $215.62M Activated in VL: True Average Daily Range Avg Daily Range: $0.52 | 3.86% Avg Daily Range (30 D): $0.11 | 4.44% Avg Daily Range (90 D): $0.08 | 4.69% Institutional Daily Volume Avg Daily Volume: 1.05M Avg Daily Volume (30 D): 1.39M Avg Daily Volume (90 D): 1.26M Trade Size Avg Trade Size (Sh.): 128 Avg Trade Size (Sh.) (30 D): 184 Avg Trade Size (Sh.) (90 D): 218 Institutional Trades Total Inst.Trades: 1,102 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $2.52M Avg Inst. Trade (90 D): $2.11M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.24M Avg Closing Trade (30 D): $6.44M Avg Closing Trade (90 D): $4.56M Avg Closing Volume: 128.98K     News Sep 6, 2024 @ 12:00 PM Ventyx Biosciences Announces Initiation of Dosing ... Source: Ventyx Biosciences, Inc. May 16, 2024 @ 8:05 PM Ventyx Biosciences to Participate in Three Upcomin... Source: Ventyx Biosciences, Inc. May 2, 2024 @ 8:05 PM Ventyx Biosciences to Report First Quarter 2024 Fi... Source: Ventyx Biosciences, Inc. Apr 30, 2024 @ 4:00 PM What Makes Ventyx Biosciences (VTYX) a New Buy Sto... Source: Zacks Equity Research Apr 5, 2024 @ 12:01 PM Kura Sushi Posts Upbeat Sales, Joins Caribou Biosc... Source: Avi Kapoor Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.75 $-.39 $-.41 Diluted EPS $-1.75 $-.39 $-.41 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -123.99M $ -27.44M $ -29.35M Operating Income / Loss $ -136.78M $ -30.1M $ -32.42M Cost of Revenue $ $ $ Net Cash Flow $ -114.59M $ M $ -34.27M PE Ratio